The influence of maintaining the correct whole blood-to-anticoagulant ratio during donation on the quality of leukoreduced whole blood.
Karger R, Lukow C, Kretschmer V
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of maintaining anticoagulant to blood ratio during blood collection rather than conventional collection on markers of RBC quality. Analytes were evaluated on the collection day and during subsequent storage at 4 degrees C. Specimens were collected from 10 blood donors of each gender and blood type (O or A D+) for each anticoagulant addition method. Male donors had hemoglobin (Hb) above 135 g/L and females had Hb above 125 g/L at their last 2 blood donations. CPDA-1 was continuously added with a roller pump to maintain the CPDA-1:blood ratio or blood was collected conventionally into bags containing CPDA-1. All blood was stored at 4 degrees C and leukoreduced 2 h after collection.
Summary of Findings
ATP levels, RBC aggregability, and factor VIII levels declined with increasing storage duration, but the effects of storage on other parameters were not discussed. On day 0, analytes were similar between the blood collected with continuous addition of CPDA-1 and blood collected conventionally, but trends toward more variability in Hb and lower AI were observed among specimens collected conventionally compared to specimens collected with continuous CPDA-1 addition. After storage of RBCs, levels of ATP, 2,3-diphosphoglycerate (2,3 DPG), potassium, glucose, lactate, free Hb, factor V, Factor VIII, fibrinogen, antithrombin (AT), and thrombin-AT complex, as well as activated partial thromboplastion time (APTT), prothrombin time (PT), thrombin time (TT), hemolysis rate, and pH were not significantly different in specimens collected with continuous addition of anticoagulant rather than collected conventionally. However, the aggregation amplitude was significantly higher and there was a trend of higher AI and lower time to 50% peak intensity (t1/2) in the conventionally collected specimens than the specimens collected with continuous addition of CPDA-1, but no differences in elongation index (EI) were observed. The difference in AI between collection groups was significant on day 21 (p0.03) but then decreased with additional storage up to 49 days while the difference in amplitude increased with storage duration.
Biospecimens
FluidBloodCellRed Blood CellsPreservation Types
Other PreservativeDiagnoses
NormalPlatforms
CarbohydrateClinical chemistry/auto analyzerSmall moleculeClinical chemistry/auto analyzerSmall moleculeEnzyme assayElectrolyte/MetalFlame emission photometryGlycoproteinClinical chemistry/auto analyzerProteinHematology/ auto analyzerProteinEnzyme assayProteinClinical chemistry/auto analyzerPeptideHematology/ auto analyzerMorphologyHematology/ auto analyzerCell count/volumeFlow cytometryCell count/volumeHematology/ auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Anticoagulant Citrate phosphate dextrose adenine 1Continuously addedIn tube/bagStorage Storage duration 0 days21 days35 days42 days49 days7 days